Rachal Laprairie v. HHS - Influenza, Guillain-Barré Syndrome (“GBS”) (2017)

Rachal Lapairie filed a petition alleging Guillain-Barré Syndrome (GBS) as a result of receiving an influenza and tetanus-acellular pertussis (Tdap) vaccine on October 8, 2013. The respondent denied that the vaccines caused the petitioner's GBS or any other injury.

The parties reached a stipulation to resolve the case, and the Special Master adopted the terms of this stipulation. The court awarded Rachal Lapairie $195,000.00 as a lump sum, representing compensation for all damages available under the program.

The decision was issued by Special Master Laura D. Millman on April 18, 2017.

The public decision does not describe the petitioner's specific symptoms, medical history, diagnostic tests, treatments, or the specific mechanism by which the vaccines allegedly caused the GBS. The names of the petitioner's counsel and respondent's counsel are listed as Craig S.

Watson and Linda S. Renzi, respectively.